197 related articles for article (PubMed ID: 36612201)
1. Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis.
Rui T; Zhang X; Guo J; Xiang A; Tang N; Liu J; Mao Z
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612201
[TBL] [Abstract][Full Text] [Related]
2. Serum Exosome-Derived piRNAs Could Be Promising Biomarkers for HCC Diagnosis.
Rui T; Wang K; Xiang A; Guo J; Tang N; Jin X; Lin Y; Liu J; Zhang X
Int J Nanomedicine; 2023; 18():1989-2001. PubMed ID: 37077942
[TBL] [Abstract][Full Text] [Related]
3. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
[TBL] [Abstract][Full Text] [Related]
5. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
6. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
7. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B
Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis.
Shi H; Jiang X; Xu C; Cheng Q
Front Endocrinol (Lausanne); 2022; 13():819056. PubMed ID: 35360081
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
10. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
12. Serum exosomal microRNA-370-3p and microRNA-196a-5p are potential biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Wei Y; Zhang Q; An L; Fang G; Hong D; Jiao T; Yang H; Wang Z
Folia Histochem Cytobiol; 2022; 60(3):215-225. PubMed ID: 35762276
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
Yu B; Zhou S; Liang H; Ye Q; Wang Y
Dig Dis Sci; 2022 Jun; 67(6):2283-2292. PubMed ID: 33982217
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of serum-related exosomal miRNAs from parathyroid tumor.
Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B
Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496
[TBL] [Abstract][Full Text] [Related]
15. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
16. Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening.
Sorop A; Iacob R; Iacob S; Constantinescu D; Chitoiu L; Fertig TE; Dinischiotu A; Chivu-Economescu M; Bacalbasa N; Savu L; Gheorghe L; Dima S; Popescu I
Front Genet; 2020; 11():712. PubMed ID: 32793278
[TBL] [Abstract][Full Text] [Related]
17. Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.
Huang C; Tang S; Shen D; Li X; Liang L; Ding Y; Xu B
Oncol Lett; 2021 Feb; 21(2):168. PubMed ID: 33552286
[TBL] [Abstract][Full Text] [Related]
18. Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma.
Cho HJ; Eun JW; Baek GO; Seo CW; Ahn HR; Kim SS; Cho SW; Cheong JY
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31968558
[TBL] [Abstract][Full Text] [Related]
19. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Liu WH; Ren LN; Wang X; Wang T; Zhang N; Gao Y; Luo H; Navarro-Alvarez N; Tang LJ
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1767-78. PubMed ID: 25724413
[TBL] [Abstract][Full Text] [Related]
20. Cellular and extracellular miRNAs are blood-compartment-specific diagnostic targets in sepsis.
Reithmair M; Buschmann D; Märte M; Kirchner B; Hagl D; Kaufmann I; Pfob M; Chouker A; Steinlein OK; Pfaffl MW; Schelling G
J Cell Mol Med; 2017 Oct; 21(10):2403-2411. PubMed ID: 28382754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
